Document is current
Any future updates will be listed below
-
Authors
Colmenero, Manuel
Roberts, Jason A.
Lipman, Jeffrey
Ulldemolins, Marta https://orcid.org/0000-0002-5050-8430
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 4 October 2025
First Online: 21 October 2025
Declarations
:
: JAR acknowledges consultancies, grant, or speaking fees from Sandoz, Qpex, Gilead, Advanz Pharma, Pfizer, MSD, and Biomerieux. MC, JL, and MU do not have conflicts of interest to declare.
